U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

U.S. President Donald Trump, Eli Lilly (LLY.N) and Novo Nordisk (NOVOb.CO) signed a deal in November to slash the prices of ...

Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for ...

None of the conference attendees who spoke to NBC News said they were opposed to Vance, who is widely expected to run. The ...

New evidence shows that remission in type 2 diabetes is attainable through weight loss, surgery, pharmacotherapy, and ...

HONG KONG SAR - Media OutReach Newswire - 19 December 2025 - Amid a global surge in demand for the weight-management ingredient GLP-1, the Hong Kong market has ...

Retatrutide works by mimicking three hunger-regulating hormones. A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising ...

Eli Lilly on Monday announced new price cuts for its popular weight loss drug Zepbound, broadening access for patients and driving greater use of the company’s digital healthcare platform, LillyDirect ...

(Reuters) -Eli Lilly said on Friday it plans to roll out an employer-focused obesity care model early next year, aiming to expand access to its blockbuster weight-loss drug through partnerships with ...

Stage two of the Supplemental Disaster Relief Program (SDRP) is moving into the initial stages of implementation, USDA officials announced during a media briefing on Monday. In what USDA Deputy ...

Prepare yourself with real insights before starting your journey with GLP-1 medications for weight loss. Glucagon-like peptide-1 (GLP-1) receptor agonists are injectable medications that were first ...